Bracket, a clinical trial technology and specialty services provider, announced the release of CUBETM, a transformative interactive response technology (IRT) solution for the life sciences industry.
The solution leverages an iterative user acceptance build experience, which allows a UAT process that study teams can visualize during the kick off meeting. Features include:
Accelerate times for sponsors and improves efficiency for CROs
Leverages Bracket's RTSM platform, but streamlines deployment through automation
Rapid project lifecycle lets sponsors experience the system prior to requirements approval
Reduce lengthy turnaround times for enhancements and in-study changes
Read the full release here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.